Image

Medical YOga dUring CANcer Treatment in a Digital or Physical Setting - a PREFERensbased Study

Medical YOga dUring CANcer Treatment in a Digital or Physical Setting - a PREFERensbased Study

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

To enhance the implementation of yoga in cancer care, studies that explore patients with cancer preferences for the execution of yoga, effects, and the experience of participating in group yoga sessions online compared to in-person sessions is required. The aim of the YouCanPrefer-study is to explore preferences, expectations, implementation, experiences, and effects of participating in in-person group yoga sessions at a yoga studio compared to participating in online-yoga at home for patients with cancer undergoing oncological treatment. Additionally, the aim is to study health-related outcomes of yoga. Patients diagnosed with cancer undergoing oncological treatment at two hospitals in Sweden will be included in the study. A preference-based allocation will be used, participants chose self if they want to participate in in-person yoga at a studio or in yoga online. Regardless of allocation, the yoga sessions will take place in a group setting once a week for a duration of 12 weeks. All participants will also have access to a yoga application on their tablets or cell phones, with a recommendation to engage in self-guided yoga for at least 10 minutes per day.

Eligibility

Inclusion Criteria:

  • Diagnosed with cancer and scheduled for or initiated oncological treatment at an oncology clinic.
  • Received written information about the study.
  • Willing to participate in the study and able to follow the protocol.
  • Understanding and expressing themselves in Swedish.
  • Age ≥ 18 years.
  • Provided informed consent.

Exclusion Criteria:

  • Patients with severe cognitive impairments such as dementia and serious psychiatric illness.
  • Patients with significant physical disabilities that may hinder yoga.
  • Patients with difficulties completing questionnaires.
  • Expected survival of less than 3 months.

Study details
    Cancer

NCT06248450

Linkoeping University

13 February 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.